Bad Pharma
2012
|
Unabridged edition
W F Howes Ltd (Verlag)
978-1-4712-1743-2 (ISBN)
W F Howes Ltd (Verlag)
978-1-4712-1743-2 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
From the bestselling author of Bad Science, Bad Pharma explores how drug companies mislead doctors and harm patients
The $600 billion pharmaceutical industry spends more on marketing than it does on research and development. New diseases are invented in order to swell profits. It distorts and suppresses the results of clinical trials if they are unfavourable. Patients' pressure groups are covertly sponsored by pill manufacturers. Its offences are countless and the consequences are felt by us all. What we trust to cure us may be ineffectual or actually harmful. Ben Goldacre is Britain's finest writer on medical matters today and Bad Pharma is a brilliant and savage attack on an industry rife with corruption.
The $600 billion pharmaceutical industry spends more on marketing than it does on research and development. New diseases are invented in order to swell profits. It distorts and suppresses the results of clinical trials if they are unfavourable. Patients' pressure groups are covertly sponsored by pill manufacturers. Its offences are countless and the consequences are felt by us all. What we trust to cure us may be ineffectual or actually harmful. Ben Goldacre is Britain's finest writer on medical matters today and Bad Pharma is a brilliant and savage attack on an industry rife with corruption.
Erscheint lt. Verlag | 16.10.2012 |
---|---|
Verlagsort | Rearsby |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Pharmazie |
Sozialwissenschaften | |
Technik | |
ISBN-10 | 1-4712-1743-4 / 1471217434 |
ISBN-13 | 978-1-4712-1743-2 / 9781471217432 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |